Hikma Pharmaceuticals

settlement

Pharma

Jazz Pharma settles Xyrem antitrust claims for $145M

The company settled with several purchaser plaintiffs in an antitrust case that involved Jazz and generic Xyrem maker Hikma Pharmaceuticals.

Zoey Becker Apr 10, 2025 8:50am

Hikma extends recall of pain drug, reports adverse event

Jul 23, 2024 1:12pm

Gavel with scales of justice in background

Amarin, after stock crash and layoffs, revives patent lawsuit

Jun 26, 2024 1:01pm

layoffs job losses cuts workforce reduction

Xellia plots 247 layoffs on the heels of Ohio plant sale

Jun 24, 2024 1:52pm

Hikma acquires some Xellia US assets for up to $185M

Jun 20, 2024 8:57am

Amarin Vascepa box

Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

Mar 29, 2024 1:10pm